Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Innocan Pharma Corp (INNO.CN)

Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Innocan Pharma Corp 1015, 926 - 5 Avenue SW Calgary AB T2P 0N7 CAN

https://www.innocanpharma.com P: 403-777-1519

Sector:

N/A

Description:

InnoCan Pharma Corp is a engaged in the development, manufacture, and marketing of cosmetic products. The company has two segments: Online sales - Sky Global operations, which engages in the development of non-CBD personal care and beauty products in the United States for online platforms such as Amazon, and other e-commerce retail sales. Other operations - the development of several drug delivery platforms, combining cannabinoids with other pharmaceutical ingredients as well as the development and sale of CBD-integrated topical products.

Key Statistics

Overview:

Market Capitalization, $K 29,242
Shares Outstanding, K 4,499
% of Institutional Shareholders 0.18%

Financials:

Annual Sales, $ 26,612 K
Annual Net Income, $ -1,124 K
Last Quarter Sales, $ 4,988 K
Last Quarter Net Income, $ 1,995 K

Growth:

1-Year Return -41.18%
3-Year Return -56.52%
5-Year Return -81.48%
5-Year Revenue Growth 406.29%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.25
EPS Growth vs. Prev Year -49.40%
Dividend Payout Ratio 0.00%
Most Recent Split 1-65 on 09/05/25

INNO.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -20.88%
Return-on-Assets % -11.36%
Profit Margin % -4.22%
Debt/Equity 0.17
Price/Sales 0.79
Price/Book 3.76
Book Value/Share 1.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.